Vontobel Holding
FOLD

Vontobel Holding’s Amicus Therapeutics FOLD Stock Holding History

Vontobel Holding’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-48,683
Closed -$397K – 1280
2025
Q1 		$397K Sell
48,683
-1,752
-3% -$16.2K ﹤0.01% 849
2024
Q4 		$475K Sell
50,435
-20,575
-29% -$214K ﹤0.01% 805
2024
Q3 		$758K Sell
71,010
-2,176
-3% -$23.7K ﹤0.01% 664
2024
Q2 		$726K Sell
73,186
-7,892
-10% -$81K ﹤0.01% 667
2024
Q1 		$955K Sell
81,078
-1,594
-2% -$20.4K 0.01% 596
2023
Q4 		$1.17M Buy
+82,672
New +$939K 0.01% 553
2021
Q4 		– Sell
-128,590
Closed -$1.23M – 1108
2021
Q3 		$1.23M Sell
128,590
-3,069
-2% -$31.4K 0.01% 567
2021
Q2 		$1.31M Buy
+131,659
New +$1.29M 0.01% 536

Other funds holding FOLD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Vontobel Holding's FOLD Position: Q2 2025 in Review

Vontobel Holding sold out of Amicus Therapeutics (FOLD) in Q2 2025, closing a stake of 48,683 shares — an estimated $397K sold.

Vontobel Holding first reported a position in FOLD in Q2 2021 and held it in 8 quarters. The position peaked at $1.31M in Q2 2021. 272 funds tracked by Wall St. Rank hold FOLD as of Q2 2025.

  • Vontobel Holding reported no remaining Amicus Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Vontobel Holding sold 48,683 Amicus Therapeutics shares in Q2 2025, an estimated $397K.
  • Vontobel Holding first reported a position in Amicus Therapeutics in Q2 2021 and held it in 8 quarters.
  • Vontobel Holding's Amicus Therapeutics position peaked at $1.31M in Q2 2021.
  • 272 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2025.

Based on Vontobel Holding's 13F filing for Q2 2025, filed 23 Jul 2025.